Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kashuba

Showing results (321-330 of 555) with videos related to

Pageof 56
Sort By:
Urologiia I Nefrologiia|March 1, 1993
[Asymptomatic bacteriuria as the manifestation of a syndrome of the activation and persistence of endogenous microflora in dynamic human adaptation to stress]B A Berdichevskiĭ, V E Tsvettsikh, G Ia Lerner, et al.
Science Translational Medicine|December 14, 2011
Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmissionKristine B Patterson, Heather A Prince, Eric Kraft, et al.
AIDS and Behavior|March 14, 2014
Measuring adherence by visual inspection of returned empty gel applicators in the CAPRISA 004 microbicide trialTanuja N Gengiah, Leila E Mansoor, Michele Upfold, et al.
JMIR Mhealth and Uhealth|September 12, 2018
Smartphone-Based Contingency Management Intervention to Improve Pre-Exposure Prophylaxis Adherence: Pilot TrialJohn T Mitchell, Sara LeGrand, Lisa B Hightow-Weidman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2014
FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxisAmy L Corneli, Jennifer Deese, Meng Wang, et al.
Pharmaceutics|March 26, 2022
Effects of Injection Volume and Route of Administration on Dolutegravir In Situ Forming Implant PharmacokineticsJordan B Joiner, Jasmine L King, Roopali Shrivastava, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Dose separation does not overcome the pharmacokinetic interaction between fosamprenavir and lopinavir/ritonavirAmanda H Corbett, Kristine B Patterson, Hsiao-Chuan Tien, et al.
Antimicrobial Agents and Chemotherapy|March 4, 2015
Mass spectrometry imaging reveals heterogeneous efavirenz distribution within putative HIV reservoirsCorbin G Thompson, Mark T Bokhart, Craig Sykes, et al.
Journal of Clinical Pharmacology|October 5, 2002
Single plasma concentrations of 1'-hydroxymidazolam or the ratio of 1'-hydroxymidazolam:midazolam do not predict midazolam clearance in healthy subjectsJanyce F Rogers, Anne N Nafziger, Angela D M Kashuba, et al.
Genomics|March 15, 1994
Construction of representative NotI linking libraries specific for the total human genome and for human chromosome 3E R Zabarovsky, R Allikmets, I Kholodnyuk, et al.
Pageof 56

Showing results (321-330 of 555) with videos related to

Sort By:
Pageof 56
Urologiia I Nefrologiia|March 1, 1993
[Asymptomatic bacteriuria as the manifestation of a syndrome of the activation and persistence of endogenous microflora in dynamic human adaptation to stress]B A Berdichevskiĭ, V E Tsvettsikh, G Ia Lerner, et al.
Science Translational Medicine|December 14, 2011
Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmissionKristine B Patterson, Heather A Prince, Eric Kraft, et al.
AIDS and Behavior|March 14, 2014
Measuring adherence by visual inspection of returned empty gel applicators in the CAPRISA 004 microbicide trialTanuja N Gengiah, Leila E Mansoor, Michele Upfold, et al.
JMIR Mhealth and Uhealth|September 12, 2018
Smartphone-Based Contingency Management Intervention to Improve Pre-Exposure Prophylaxis Adherence: Pilot TrialJohn T Mitchell, Sara LeGrand, Lisa B Hightow-Weidman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2014
FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxisAmy L Corneli, Jennifer Deese, Meng Wang, et al.
Pharmaceutics|March 26, 2022
Effects of Injection Volume and Route of Administration on Dolutegravir In Situ Forming Implant PharmacokineticsJordan B Joiner, Jasmine L King, Roopali Shrivastava, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Dose separation does not overcome the pharmacokinetic interaction between fosamprenavir and lopinavir/ritonavirAmanda H Corbett, Kristine B Patterson, Hsiao-Chuan Tien, et al.
Antimicrobial Agents and Chemotherapy|March 4, 2015
Mass spectrometry imaging reveals heterogeneous efavirenz distribution within putative HIV reservoirsCorbin G Thompson, Mark T Bokhart, Craig Sykes, et al.
Journal of Clinical Pharmacology|October 5, 2002
Single plasma concentrations of 1'-hydroxymidazolam or the ratio of 1'-hydroxymidazolam:midazolam do not predict midazolam clearance in healthy subjectsJanyce F Rogers, Anne N Nafziger, Angela D M Kashuba, et al.
Genomics|March 15, 1994
Construction of representative NotI linking libraries specific for the total human genome and for human chromosome 3E R Zabarovsky, R Allikmets, I Kholodnyuk, et al.
Pageof 56